The present invention is, in general, directed to devices and methods for the in vivo monitoring of an analyte, such as glucose or lactate, using a sensor to provide information to a patient about the level of the analyte. More particularly, the present invention relates to devices and methods for inserting a subcutaneously implantable electrochemical sensor in a patient for such monitoring.
The monitoring of the level of glucose or other analytes, such as lactate or oxygen, in certain individuals is vitally important to their health. High or low levels of glucose or other analytes may have detrimental effects. The monitoring of glucose is particularly important to individuals with diabetes, as they must determine when insulin is needed to reduce glucose levels in their bodies or when additional glucose is needed to raise the level of glucose in their bodies.
A conventional technique used by many diabetics for personally monitoring their blood glucose level includes the periodic drawing of blood, the application of that blood to a test strip, and the determination of the blood glucose level using calorimetric, electrochemical, or photometric detection. This technique does not permit continuous or automatic monitoring of glucose levels in the body, but typically must be performed manually on a periodic basis. Unfortunately, the consistency with which the level of glucose is checked varies widely among individuals. Many diabetics find the periodic testing inconvenient and they sometimes forget to test their glucose level or do not have time for a proper test. In addition, some individuals wish to avoid the pain associated with the test. These situations may result in hyperglycemic or hypoglycemic episodes. An in vivo glucose sensor that continuously or automatically monitors the individual's glucose level would enable individuals to more easily monitor their glucose, or other analyte, levels.
A variety of devices have been developed for continuous or automatic monitoring of analytes, such as glucose, in the blood stream or interstitial fluid. A number of these devices use electrochemical sensors which are directly implanted into a blood vessel or in the subcutaneous tissue of a patient. However, these devices are often difficult to reproducibly and inexpensively manufacture in large numbers. In addition, these devices are typically large, bulky, and/or inflexible, and many can not be used effectively outside of a controlled medical facility, such as a hospital or a doctor's office, unless the patient is restricted in his activities.
Some devices include a sensor guide which rests on or near the skin of the patient and may be attached to the patient to hold the sensor in place. These sensor guides are typically bulky and do not allow for freedom of movement. In addition, the sensor guides or the sensors include cables or wires for connecting the sensor to other equipment to direct the signals from the sensors to an analyzer. The size of the sensor guides and presence of cables and wires hinders the convenient use of these devices for everyday applications. The patient's comfort and the range of activities that can be performed while the sensor is implanted are important considerations in designing extended-use sensors for continuous or automatic in vivo monitoring of the level of an analyte, such as glucose. There is a need for a small, comfortable device which can continuously monitor the level of an analyte, such as glucose, while still permitting the patient to engage in normal activities. Continuous and/or automatic monitoring of the analyte can provide a warning to the patient when the level of the analyte is at or near a threshold level. For example, if glucose is the analyte, then the monitoring device might be configured to warn the patient of current or impending hyperglycemia or hypoglycemia. The patient can then take appropriate actions.
Generally, the present invention relates to methods and devices for the continuous and/or automatic in vivo monitoring of the level of an analyte using a subcutaneously implantable sensor. Many of these devices are small and comfortable when used, thereby allowing a wide range of activities. One embodiment includes a sensor control unit having a housing adapted for placement on skin. The housing is also adapted to receive a portion of an electrochemical sensor. The sensor control unit includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The sensor control unit may also include a variety of optional components, such as, for example, adhesive for adhering to the skin, a mounting unit, a receiver, a processing circuit, a power supply (e.g., a battery), an alarm system, a data storage unit, a watchdog circuit, and a measurement circuit. The sensor itself has at least one working electrode and at least one contact pad coupled to the working electrode or electrodes. The sensor may also include optional components, such as, for example, a counter electrode, a counter/reference electrode, a reference electrode, and a temperature probe. The analyte monitoring system also includes a display unit that has a receiver for receiving data from the sensor control unit and a display coupled to the receiver for displaying an indication of the level of an analyte. The display unit may optionally include a variety of components, such as, for example, a transmitter, an analyzer, a data storage unit, a watchdog circuit, an input device, a power supply, a clock, a lamp, a pager, a telephone interface, a computer interface, an alarm or alarm system, a radio, and a calibration unit. In addition, the analyte monitoring system or a component of the analyte monitoring system may optionally include a processor capable of determining a drug or treatment protocol and/or a drug delivery system.
According to one aspect of the invention, an insertion kit is disclosed for inserting an electrochemical sensor into a patient. The insertion kit includes an introducer. A portion of the introducer has a sharp, rigid, planer structure adapted to support the sensor during insertion of the electrochemical sensor. The insertion kit also includes an insertion gun having a port configured to accept the electrochemical sensor and the introducer. The insertion gun has a driving mechanism for driving the introducer and electrochemical sensor into the patient, and a retraction mechanism for removing the introducer while leaving the sensor within the patient.
According to another aspect of the invention, a method of using an electrochemical sensor is disclosed. A mounting unit is adhered to skin of a patient. An insertion gun is aligned with a port on the mounting unit. The electrochemical sensor is disposed within the insertion gun and then the electrochemical sensor is inserted into the skin of the patient using the insertion gun. The insertion gun is removed and a housing of the sensor control unit is mounted on the mounting base. A plurality of conductive contacts disposed on the housing is coupled to a plurality of contact pads disposed on the electrochemical sensor to prepare the sensor for use.
The above summary of the present invention is not intended to describe each disclosed embodiment or every implementation of the present invention. The Figures and the detailed description which follow more particularly exemplify these embodiments.
The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.
The present invention is applicable to an analyte monitoring system using an implantable sensor for the in vivo determination of a concentration of an analyte, such as glucose or lactate, in a fluid. The sensor can be, for example, subcutaneously implanted in a patient for the continuous or periodic monitoring an analyte in a patient's interstitial fluid. This can then be used to infer the glucose level in the patient's bloodstream. Other in vivo analyte sensors can be made, according to the invention, for insertion into a vein, artery, or other portion of the body containing fluid. The analyte monitoring system is typically configured for monitoring the level of the analyte over a time period which may range from days to weeks or longer.
The analyte monitoring systems of the present invention can be utilized under a variety of conditions. The particular configuration of a sensor and other units used in the analyte monitoring system may depend on the use for which the analyte monitoring system is intended and the conditions under which the analyte monitoring system will operate. One embodiment of the analyte monitoring system includes a sensor configured for implantation into a patient or user. For example, implantation of the sensor may be made in the arterial or venous systems for direct testing of analyte levels in blood. Alternatively, a sensor may be implanted in the interstitial tissue for determining the analyte level in interstitial fluid. This level may be correlated and/or converted to analyte levels in blood or other fluids. The site and depth of implantation may affect the particular shape, components, and configuration of the sensor. Subcutaneous implantation may be preferred, in some cases, to limit the depth of implantation of the sensor. Sensors may also be implanted in other regions of the body to determine analyte levels in other fluids. Examples of suitable sensor for use in the analyte monitoring systems of the invention are described in U.S. patent application Ser. No. 09/034,372 and Ser. No. 09/753,746 (the complete parent application to this CIP), both incorporated herein by reference.
One embodiment of the analyte monitoring system 40 for use with an implantable sensor 42, and particularly for use with a subcutaneously implantable sensor, is illustrated in block diagram form in
A sensor 42 includes at least one working electrode 58 formed on a substrate 50, as shown in
In some embodiments, the substrate is flexible. For example, if the sensor 42 is configured for implantation into a patient, then the sensor 42 may be made flexible (although rigid sensors may also be used for implantable sensors) to reduce pain to the patient and damage to the tissue caused by the implantation of and/or the wearing of the sensor 42. A flexible substrate 50 often increases the patient's comfort and allows a wider range of activities. Suitable materials for a flexible substrate 50 include, for example, non-conducting plastic or polymeric materials and other non-conducting, flexible, deformable materials. Examples of useful plastic or polymeric materials include thermoplastics such as polycarbonates, polyesters (e.g., Mylar™ and polyethylene terephthalate (PET)), polyvinyl chloride (PVC), polyurethanes, polyethers, polyamides, polyimides, or copolymers of these thermoplastics, such as PETG (glycol-modified polyethylene terephthalate).
In other embodiments, the sensors 42 are made using a relatively rigid substrate 50 to, for example, provide structural support against bending or breaking. Examples of rigid materials that may be used as the substrate 50 include poorly conducting ceramics, such as aluminum oxide and silicon dioxide. One advantage of an implantable sensor 42 having a rigid substrate is that the sensor 42 may have a sharp point and/or a sharp edge to aid in implantation of a sensor 42 without an additional introducer.
It will be appreciated that for many sensors 42 and sensor applications, both rigid and flexible sensors will operate adequately. The flexibility of the sensor 42 may also be controlled and varied along a continuum by changing, for example, the composition and/or thickness of the substrate 50.
In addition to considerations regarding flexibility, it is often desirable that implantable sensors 42 should have a substrate 50 which is non-toxic. Preferably, the substrate 50 is approved by one or more appropriate governmental agencies or private groups for in vivo use.
Although the substrate 50 in at least some embodiments has uniform dimensions along the entire length of the sensor 42, in other embodiments, the substrate 50 has a distal end 67 and a proximal end 65 with different widths 53, 55, respectively, as illustrated in
An introducer 120 can be used to subcutaneously insert the sensor 42 into the patient, as illustrated in
The introducer 120 may have a variety of cross-sectional shapes, as shown in
The sensor 42 itself may include optional features to facilitate insertion. For example, the sensor 42 may be pointed at the tip 123 to ease insertion, as illustrated in
In operation, the sensor 42 is placed within or next to the introducer 120 and then a force is provided against the introducer 120 and/or sensor 42 to carry the sensor 42 into the skin of the patient. In one embodiment, the force is applied to the sensor 42 to push the sensor into the skin, while the introducer 120 remains stationary and provides structural support to the sensor 42. Alternatively, the force is applied to the introducer 120 and optionally to the sensor 42 to push a portion of both the sensor 42 and the introducer 120 through the skin of the patient and into the subcutaneous tissue. The introducer 120 is optionally pulled out of the skin and subcutaneous tissue with the sensor 42 remaining in the subcutaneous tissue due to frictional forces between the sensor 42 and the patient's tissue. If the sensor 42 includes the optional barb 125, then this structure may also facilitate the retention of the sensor 42 within the interstitial tissue as the barb catches in the tissue.
The force applied to the introducer 120 and/or the sensor 42 may be applied manually or mechanically. Preferably, the sensor 42 is reproducibly inserted through the skin of the patient. In one embodiment, an insertion gun is used to insert the sensor. One example of an insertion gun 200 for inserting a sensor 42 is shown in
After the sensor 42 is inserted, the insertion gun 200 may contain a mechanism which pulls the introducer 120 out of the skin of the patient. Such a mechanism may use a spring, electromagnet, or the like to remove the introducer 120.
The insertion gun may be reusable. The introducer 120 is often disposable to avoid the possibility of contamination. Alternatively, the introducer 120 may be sterilized and reused. In addition, the introducer 120 and/or the sensor 42 may be coated with an anticlotting agent to prevent fouling of the sensor 42.
In one embodiment, the sensor 42 is injected between 2 to 12 mm into the interstitial tissue of the patient for subcutaneous implantation. Preferably, the sensor is injected 3 to 9 mm, and more preferably 5 to 7 mm, into the interstitial tissue. Other embodiments of the invention, may include sensors implanted in other portions of the patient, including, for example, in an artery, vein, or organ. The depth of implantation varies depending on the desired implantation target.
Although the sensor 42 may be inserted anywhere in the body, it is often desirable that the insertion site be positioned so that the on-skin sensor control unit 44 can be concealed. In addition, it is often desirable that the insertion site be at a place on the body with a low density of nerve endings to reduce the pain to the patient. Examples of preferred sites for insertion of the sensor 42 and positioning of the on-skin sensor control unit 44 include the abdomen, thigh, leg, upper arm, and shoulder.
An insertion angle is measured from the plane of the skin (i.e., inserting the sensor perpendicular to the skin would be a 90° insertion angle). Insertion angles usually range from 10 to 90°, typically from 15 to 60°, and often from 30 to 45°.
On-skin Sensor Control Unit
The on-skin sensor control unit 44 is configured to be placed on the skin of a patient. The on-skin sensor control unit 44 is optionally formed in a shape that is comfortable to the patient and which may permit concealment, for example, under a patient's clothing. The thigh, leg, upper arm, shoulder, or abdomen are convenient parts of the patient's body for placement of the on-skin sensor control unit 44 to maintain concealment. However, the on-skin sensor control unit 44 may be positioned on other portions of the patient's body. One embodiment of the on-skin sensor control unit 44 has a thin, oval shape to enhance concealment, as illustrated in
The particular profile, as well as the height, width, length, weight, and volume of the on-skin sensor control unit 44 may vary and depends, at least in part, on the components and associated functions included in the on-skin sensor control unit 44, as discussed below. For example, in some embodiments, the on-skin sensor control unit 44 has a height of 1.3 cm or less, and preferably 0.7 cm or less. In some embodiments, the on-skin sensor control unit 44 has a weight of 90 grams or less, preferably 45 grams or less, and more preferably 25 grams or less. In some embodiments, the on-skin sensor control unit 44 has a volume of about 15 cm3 or less, preferably about 10 cm3 or less, more preferably about 5 cm3 or less, and most preferably about 2.5 cm3 or less.
The on-skin sensor control unit 44 includes a housing 45, as illustrated in
In some embodiments, conductive contacts 80 are provided on the exterior of the housing 45. In other embodiments, the conductive contacts 80 are provided on the interior of the housing 45, for example, within a hollow or recessed region.
In some embodiments, the housing 45 of the on-skin sensor control unit 44 is a single piece. The conductive contacts 80 may be formed on the exterior of the housing 45 or on the interior of the housing 45 provided there is a port 78 in the housing 45 through which the sensor 42 can be directed to access the conductive contacts 80.
In other embodiments, the housing 45 of the on-skin sensor control unit 44 is formed in at least two separate portions that fit together to form the housing 45, for example, a base 74 and a cover 76, as illustrated in
These two or more separate portions of the housing 45 of the on-skin sensor control unit 44 may have complementary, interlocking structures, such as, for example, interlocking ridges or a ridge on one component and a complementary groove on another component, so that the two or more separate components may be easily and/or firmly coupled together. This may be useful, particularly if the components are taken apart and fit together occasionally, for example, when a battery or sensor 42 is replaced. However, other fasteners may also be used to couple the two or more components together, including, for example, screws, nuts and bolts, nails, staples, rivets, or the like. In addition, adhesives, both permanent or temporary, may be used including, for example, contact adhesives, pressure sensitive adhesives, glues, epoxies, adhesive resins, and the like.
Typically, the housing 45 is at least water resistant to prevent the flow of fluids into contact with the components in the housing, including, for example, the conductive contacts 80. Preferably, the housing is waterproof. In one embodiment, two or more components of the housing 45, for example, the base 74 and the cover 76, fit together tightly to form a hermetic, waterproof, or water resistant seal so that fluids can not flow into the interior of the on-skin sensor control unit 44. This may be useful to avoid corrosion currents and/or degradation of items within the on-skin sensor control unit 44, such as the conductive contacts, the battery, or the electronic components, particularly when the patient engages in such activities as showering, bathing, or swimming.
Water resistant, as used herein, means that there is no penetration of water through a water resistant seal or housing when immersed in water at a depth of one meter at sea level. Waterproof, as used herein, means that there is no penetration of water through the waterproof seal or housing when immersed in water at a depth of ten meters, and preferably fifty meters, at sea level. It is often desirable that the electronic circuitry, power supply (e.g., battery), and conductive contacts of the on-skin sensor control unit, as well as the contact pads of the sensor, are contained in a water resistant, and preferably, a waterproof, environment.
The on-skin sensor control unit 44 is typically attached to the skin 75 of the patient, as illustrated in
Another method of attaching the housing 45 of the on-skin sensor control unit 44 to the skin 75 includes using a mounting unit, 77. The mounting unit 77 is often a part of the on-skin sensor control unit 44. One example of a suitable mounting unit 77 is a double-sided adhesive strip, one side of which is adhered to a surface of the skin of the patient and the other side is adhered to the on-skin sensor control unit 44. In this embodiment, the mounting unit 77 may have an optional opening 79 which is large enough to allow insertion of the sensor 42 through the opening 79. Alternatively, the sensor may be inserted through a thin adhesive and into the skin.
A variety of adhesives may be used to adhere the on-skin sensor control unit 44 to the skin 75 of the patient, either directly or using the mounting unit 77, including, for example, pressure sensitive adhesives (PSA) or contact adhesives. Preferably, an adhesive is chosen which is not irritating to all or a majority of patients for at least the period of time that a particular sensor 42 is implanted in the patient. Alternatively, a second adhesive or other skin-protecting compound may be included with the mounting unit so that a patient, whose skin is irritated by the adhesive on the mounting unit 77, can cover his skin with the second adhesive or other skin-protecting compound and then place the mounting unit 77 over the second adhesive or other skin-protecting compound. This should substantially prevent the irritation of the skin of the patient because the adhesive on the mounting unit 77 is no longer in contact with the skin, but is instead in contact with the second adhesive or other skin-protecting compound.
Returning to
Another embodiment of a mounting unit 77 used in an on-skin sensor control unit 44 is illustrated in
The mounting unit 77 typically includes an adhesive on a bottom surface of the mounting unit 77 to adhere to the skin of the patient or the mounting unit 77 is used in conjunction with, for example, double-sided adhesive tape or the like. The mounting unit 77 typically includes an opening 79 through which the sensor 42 is inserted, as shown in
In another embodiment, a coupled mounting unit 77 and housing 45 of an on-skin sensor control unit 44 is provided on an adhesive patch 204 with an optional cover 206 to protect and/or confine the housing 45 of the on-skin sensor control unit 44, as illustrated in
In some embodiments, the adhesive on the on-skin sensor control unit 44 and/or on any of the embodiments of the mounting unit 77 is water resistant or waterproof to permit activities such as showering and/or bathing while maintaining adherence of the on-skin sensor control unit 44 to the skin 75 of the patient and, at least in some embodiments, preventing water from penetrating into the sensor control unit 44. The use of a water resistant or waterproof adhesive combined with a water resistant or waterproof housing 45 protects the components in the sensor control unit 44 and the contact between the conductive contacts 80 and the sensor 42 from damage or corrosion. An example of a non-irritating adhesive that repels water is Tegaderm (3M, St. Paul, Minn.).
In one embodiment, the on-skin sensor control unit 44 includes a sensor port 78 through which the sensor 42 enters the subcutaneous tissue of the patient, as shown in
Alternatively, if the conductive contacts 80 are within the housing 45 the patient may slide the sensor 42 into the housing 45 until contact is made between the contact pads 49 and the conductive contacts 80. The sensor control unit 44 may have a structure which obstructs the sliding of the sensor 42 further into the housing once the sensor 42 is properly positioned with the contact pads 49 in contact with the conductive contacts 80.
In other embodiments, the conductive contacts 80 are on the exterior of the housing 45 (see e.g.,
In some embodiments, when the sensor 42 is inserted using an introducer 120 (see
In some embodiments, the shapes of a) the guides, opening 79, or sensor port 78, and (b) the introducer 120 or insertion gun 200 are configured such that the two shapes can only be matched in a single orientation. This aids in inserting the sensor 42 in the same orientation each time a new sensor is inserted into the patient. This uniformity in insertion orientation may be required in some embodiments to ensure that the contact pads 49 on the sensor 42 are correctly aligned with appropriate conductive contacts 80 on the on-skin sensor control unit 44. In addition, the use of the insertion gun, as described above, may ensure that the sensor 42 is inserted at a uniform, reproducible depth.
An exemplary on-skin sensor control unit 44 can be prepared and used in the following manner. A mounting unit 77 having adhesive on the bottom is applied to the skin. An insertion gun 200 (see
The introducer, sensor, insertion gun and mounting unit can be manufactured, marketed, or sold as a unit. For example,
In one embodiment, the insertion gun 274 is packaged in a state where it is ready to thrust the sensor 272 (and perhaps introducer 270) into subcutaneous tissue. For example, the insertion gun 274 can be packaged in a “cocked” state, such that the thrusting force used to introduce the sensor 272 into the subcutaneous tissue is stored in the device as potential energy (in the case of the embodiment depicted in
Referring to
As an overview of the operation of inserter kit 300, the kit comes packaged generally as shown in
Referring to
Referring to
Sensor 314 has a main surface 346 slidably mounted between U-shaped rails 348 of introducer sharp 340 and releasably retained there by sensor dimple 350 which engages introducer dimple 352. Introducer sharp 340 is mounted to face 354 of shuttle 338, such as with adhesive, heat stake or ultrasonic weld. Sensor 314 also has a surface 356 that extends orthogonally from main surface 346 and just beneath a driving surface 358 of shuttle 338 when mounted thereon (details of these features are better shown in FIGS. 19 and 25-27.)
Shuttle 338 is slidably and non-rotabably constrained on base 344 by arcuate guides 360. As best seen in
Actuator button 324 is slidably received within housing 334 from below and resides in opening 376 at the top of housing 334 with limited longitudinal movement. Arms 378 on each side of actuator button 324 travel in channels 380 along the inside walls of housing 334, as best seen in
When sensor 314, introducer 340, shuttle 338, retraction spring 342, drive spring 336 and actuator button 324 are assembled between base 344 and housing 334 as shown in
Referring to
Referring to
Referring to
Referring to
Referring to
Referring again to
Referring to
In the preferred embodiment, sensor 314 is made from a 0.005 inch thick Mylar substrate, such as Dupont Melinex ST-505, print treated both sides, heat stabilized and bi-axially oriented. Main surface 346 is 0.315 tall by 0.512 wide, and orthogonal surface 356 is 0.374 wide by 0.202 deep. Sensor tail 431 is 0.230 long by 0.023 wide. Semispherical sensor dimple 350 is 0.050 inches wide and 0.026 inches deep. Introducer 340 is made from SUS 301 medical grade stainless steel, 0.004 inches thick, having a surface roughness less than or equal to 0.5 micrometers. The height of the main portion of introducer 340 is 0.614 inches, and the inside width is 0.513 inches. The overall thickness of rolled rails 348 is 0.026 inches. The length and width of introducer tail 424 are 0.354 and 0.036 inches, respectively. The preferred angle of the sharp 340 is 21 degrees. Preferably, semispherical introducer dimple 352 has a radius of 0.024 inches. In the preferred embodiment, shuttle 338 has an average speed of at least 1 meter/second, and has a momentum at its end of travel of about 2.65 lb-m/sec.
Preferably, housing 334, button 324, shuttle 338, base 344 and mount 312 are all injection molded from G.E. Lexan PC. Inside and outside working surfaces of arms 378 on button 324 are preferably lubricated with Dow Corning 360 Medical Fluid. Drive spring 336 has a free length of 1.25 inches, a working length of 1.00 inch, and a rate between 20 and 30 pounds per inch. Retraction spring 342 has a free length of 1.5 inches, a working length of 0.35 inches, and a rate between 0.15 and 0.35 pounds per inch. Adhesive tape 320 preferably is medical grade acrylic adhesive on polyester film (such as Acutek 0396013) with a semi-bleached kraft liner having silicon release.
Referring to
Referring to
Referring to
Referring to
Seal 442 is preferably made of shore A 30 durometer compression molded silicone. It is envisioned that seal 442 can be shortened in the axial direction (parallel to springs 456) to reduce the force required to compress it when attaching transmitter 330 to mount 312. Best results for fastening seal 442 to transmitter housing 330 have been achieved with double sided adhesive tape 320, silicone adhesive on one side and acrylic adhesive on the other for sticking to the PC-ABS blend of the transmitter housing 330, such as product number 9731 manufactured by 3M Company of St. Paul, Minn. Springs 456 are preferably made from gold-plated beryllium copper so as to deter galvanic current effects. Preferably, main surface 346 of sensor 314 that contacts seal 442 has a uniform thickness dielectric coating with a window in it (i.e. no dielectric) where springs 456 contact sensor 314. An interconnect 440 constructed as described above remains water proof when submerged to a depth of at least 1 meter for 45 minutes.
To increase the reliability of sensor insertion, the following enhancements can be added to the inserter kit 300 described above. First, a sensor flap 466, as shown in
Referring to
Safety lock key 476 can be provided to prevent actuator button 324′ from being pressed until key 476 is removed. Aperture 478 is provided in the top center of bridge 470 for receiving boss 480 located at the bottom of key 476, thereby allowing key 476 to rotate. When key handle 482 is rotated perpendicular to button protrusions 474 as shown, two opposing perpendicular fins 484 on key 476 swing into inwardly facing slots (not shown) on the inside of protrusions 474 and prevent button 324′ from being actuated. When key handle 482 and fins 484 are rotated parallel to button protrusions 474 such that fins 484 disengage therefrom, key 476 can be removed and button 324′ can then be actuated. Other than these modifications, this inserter kit 300′ functions the same as the embodiment previous described.
To provide an easier and more consistent release of shuttle 338 by actuator button 324 or 324′, it is envisioned that less aggressive finger engagement with stops 386 can be employed, or the above designs can be modified to have a single, more centrally located shuttle release finger (not shown) instead of the two outboard fingers 412 shown.
The present invention should not be considered limited to the particular examples described above. Various modifications, equivalent processes, as well as numerous structures to which the present invention may be applicable and which fall within the general scope of the invention will be readily apparent to those of skill in the art to which the present invention is directed upon review of the instant specification.
This non-provisional application is related to and claims priority based on U.S. Provisional Application No. 60/424,099, entitled “Sensor Inserter Device and Methods of Use,” filed on Nov. 5, 2002, which is incorporated herein in its entirety by this reference.
Number | Name | Date | Kind |
---|---|---|---|
3260656 | Ross, Jr. | Jul 1966 | A |
3653841 | Klein | Apr 1972 | A |
3719564 | Lilly, Jr. et al. | Mar 1973 | A |
3776832 | Oswin et al. | Dec 1973 | A |
3837339 | Aisenberg et al. | Sep 1974 | A |
3926760 | Allen et al. | Dec 1975 | A |
3972320 | Kalman | Aug 1976 | A |
3979274 | Newman | Sep 1976 | A |
4008717 | Kowarski | Feb 1977 | A |
4016866 | Lawton | Apr 1977 | A |
4055175 | Clemens et al. | Oct 1977 | A |
4059406 | Fleet | Nov 1977 | A |
4076596 | Connery et al. | Feb 1978 | A |
4098574 | Dappen | Jul 1978 | A |
4100048 | Pompei et al. | Jul 1978 | A |
4129128 | McFarlane | Dec 1978 | A |
4151845 | Clemens | May 1979 | A |
4168205 | Danninger et al. | Sep 1979 | A |
4172770 | Semersky et al. | Oct 1979 | A |
4178916 | McNamara | Dec 1979 | A |
4206755 | Klein | Jun 1980 | A |
4224125 | Nakamura et al. | Sep 1980 | A |
4240438 | Updike et al. | Dec 1980 | A |
4247297 | Berti et al. | Jan 1981 | A |
4340458 | Lerner et al. | Jul 1982 | A |
4352960 | Dormer et al. | Oct 1982 | A |
4356074 | Johnson | Oct 1982 | A |
4365637 | Johnson | Dec 1982 | A |
4366033 | Richter et al. | Dec 1982 | A |
4375399 | Havas et al. | Mar 1983 | A |
4384586 | Christiansen | May 1983 | A |
4390621 | Bauer | Jun 1983 | A |
4401122 | Clark, Jr. | Aug 1983 | A |
4404066 | Johnson | Sep 1983 | A |
4418148 | Oberhardt | Nov 1983 | A |
4427770 | Chen et al. | Jan 1984 | A |
4431004 | Bessman et al. | Feb 1984 | A |
4436094 | Cerami | Mar 1984 | A |
4440175 | Wilkins | Apr 1984 | A |
4450842 | Zick et al. | May 1984 | A |
4458686 | Clark, Jr. | Jul 1984 | A |
4461691 | Frank | Jul 1984 | A |
4469110 | Slama | Sep 1984 | A |
4477314 | Richter et al. | Oct 1984 | A |
4484987 | Gough | Nov 1984 | A |
4522690 | Venkatasetty | Jun 1985 | A |
4524114 | Samuels et al. | Jun 1985 | A |
4526661 | Steckhan et al. | Jul 1985 | A |
4534356 | Papadakis | Aug 1985 | A |
4538616 | Rogoff | Sep 1985 | A |
4543955 | Schroeppel | Oct 1985 | A |
4545382 | Higgins et al. | Oct 1985 | A |
4552840 | Riffer | Nov 1985 | A |
4560534 | Kung et al. | Dec 1985 | A |
4571292 | Liu et al. | Feb 1986 | A |
4573994 | Fischell et al. | Mar 1986 | A |
4581336 | Malloy et al. | Apr 1986 | A |
4595011 | Phillips | Jun 1986 | A |
4619754 | Niki et al. | Oct 1986 | A |
4627445 | Garcia et al. | Dec 1986 | A |
4627908 | Miller | Dec 1986 | A |
4633878 | Bombardieri | Jan 1987 | A |
4637403 | Garcia et al. | Jan 1987 | A |
4650547 | Gough | Mar 1987 | A |
4654197 | Lilja et al. | Mar 1987 | A |
4655880 | Liu | Apr 1987 | A |
4655885 | Hill et al. | Apr 1987 | A |
4671288 | Gough | Jun 1987 | A |
4679562 | Luksha | Jul 1987 | A |
4680268 | Clark, Jr. | Jul 1987 | A |
4682602 | Prohaska | Jul 1987 | A |
4684537 | Graetzel et al. | Aug 1987 | A |
4685463 | Williams | Aug 1987 | A |
4703756 | Gough et al. | Nov 1987 | A |
4711245 | Higgins et al. | Dec 1987 | A |
4717673 | Wrighton et al. | Jan 1988 | A |
4721601 | Wrighton et al. | Jan 1988 | A |
4721677 | Clark, Jr. | Jan 1988 | A |
4726378 | Kaplan | Feb 1988 | A |
4726716 | McGuire | Feb 1988 | A |
4731726 | Allen, III | Mar 1988 | A |
4757022 | Shults et al. | Jul 1988 | A |
4758323 | Davis et al. | Jul 1988 | A |
4759371 | Franetzki | Jul 1988 | A |
4759828 | Young et al. | Jul 1988 | A |
4764416 | Ueyama et al. | Aug 1988 | A |
4776944 | Janata et al. | Oct 1988 | A |
4781798 | Gough | Nov 1988 | A |
4784736 | Lonsdale et al. | Nov 1988 | A |
4795707 | Niiyama et al. | Jan 1989 | A |
4796634 | Huntsman et al. | Jan 1989 | A |
4805624 | Yao et al. | Feb 1989 | A |
4813424 | Wilkins | Mar 1989 | A |
4815469 | Cohen et al. | Mar 1989 | A |
4820399 | Senda et al. | Apr 1989 | A |
4822337 | Newhouse et al. | Apr 1989 | A |
4830959 | McNeil et al. | May 1989 | A |
4832797 | Vadgama et al. | May 1989 | A |
RE32947 | Dormer et al. | Jun 1989 | E |
4840893 | Hill et al. | Jun 1989 | A |
4848351 | Finch | Jul 1989 | A |
4871351 | Feingold | Oct 1989 | A |
4871440 | Nagata et al. | Oct 1989 | A |
4874500 | Madou et al. | Oct 1989 | A |
4890620 | Gough | Jan 1990 | A |
4894137 | Takizawa et al. | Jan 1990 | A |
4897162 | Lewandowski et al. | Jan 1990 | A |
4897173 | Nankai et al. | Jan 1990 | A |
4909908 | Ross et al. | Mar 1990 | A |
4911794 | Parce et al. | Mar 1990 | A |
4917800 | Lonsdale et al. | Apr 1990 | A |
4919141 | Zier et al. | Apr 1990 | A |
4919767 | Vadgama et al. | Apr 1990 | A |
4923586 | Katayama et al. | May 1990 | A |
4927516 | Yamaguchi et al. | May 1990 | A |
4934369 | Maxwell | Jun 1990 | A |
4935105 | Churchouse | Jun 1990 | A |
4935345 | Guilbeau et al. | Jun 1990 | A |
4938860 | Wogoman | Jul 1990 | A |
4944299 | Silvian | Jul 1990 | A |
4950378 | Nagata | Aug 1990 | A |
4953552 | DeMarzo | Sep 1990 | A |
4954129 | Giuliani et al. | Sep 1990 | A |
4969468 | Byers et al. | Nov 1990 | A |
4970145 | Bennetto et al. | Nov 1990 | A |
4974929 | Curry | Dec 1990 | A |
4986271 | Wilkins | Jan 1991 | A |
4994167 | Shults et al. | Feb 1991 | A |
5001054 | Wagner | Mar 1991 | A |
5035860 | Kleingeld et al. | Jul 1991 | A |
5036860 | Leigh et al. | Aug 1991 | A |
5050612 | Matsumura | Sep 1991 | A |
5058592 | Whisler | Oct 1991 | A |
5070535 | Hochmair et al. | Dec 1991 | A |
5082550 | Rishpon et al. | Jan 1992 | A |
5082786 | Nakamoto | Jan 1992 | A |
5089112 | Skotheim et al. | Feb 1992 | A |
5095904 | Seligman et al. | Mar 1992 | A |
5101814 | Palti | Apr 1992 | A |
5108564 | Szuminsky et al. | Apr 1992 | A |
5109850 | Blanco et al. | May 1992 | A |
5120420 | Nankai et al. | Jun 1992 | A |
5126034 | Carter et al. | Jun 1992 | A |
5133856 | Yamaguchi et al. | Jul 1992 | A |
5135003 | Souma | Aug 1992 | A |
5141868 | Shanks et al. | Aug 1992 | A |
5161532 | Joseph | Nov 1992 | A |
5165407 | Wilson et al. | Nov 1992 | A |
5174291 | Schoonen et al. | Dec 1992 | A |
5190041 | Palti | Mar 1993 | A |
5192416 | Wang et al. | Mar 1993 | A |
5198367 | Aizawa et al. | Mar 1993 | A |
5202261 | Musho et al. | Apr 1993 | A |
5205920 | Oyama et al. | Apr 1993 | A |
5208154 | Weaver et al. | May 1993 | A |
5209229 | Gilli | May 1993 | A |
5217595 | Smith et al. | Jun 1993 | A |
5229282 | Yoshioka et al. | Jul 1993 | A |
5250439 | Musho et al. | Oct 1993 | A |
5262035 | Gregg et al. | Nov 1993 | A |
5262305 | Heller et al. | Nov 1993 | A |
5264103 | Yoshioka et al. | Nov 1993 | A |
5264104 | Gregg et al. | Nov 1993 | A |
5264106 | McAleer et al. | Nov 1993 | A |
5271815 | Wong | Dec 1993 | A |
5279294 | Anderson et al. | Jan 1994 | A |
5284156 | Schramm et al. | Feb 1994 | A |
5286362 | Hoenes et al. | Feb 1994 | A |
5286364 | Yacynych et al. | Feb 1994 | A |
5288636 | Pollmann et al. | Feb 1994 | A |
5293546 | Tadros et al. | Mar 1994 | A |
5320098 | Davidson | Jun 1994 | A |
5320725 | Gregg et al. | Jun 1994 | A |
5322063 | Allen et al. | Jun 1994 | A |
5337747 | Neftel | Aug 1994 | A |
5352348 | Young et al. | Oct 1994 | A |
5356786 | Heller et al. | Oct 1994 | A |
5368028 | Palti | Nov 1994 | A |
5372133 | Hogen Esch | Dec 1994 | A |
5376251 | Kaneko et al. | Dec 1994 | A |
5378628 | Gratzel et al. | Jan 1995 | A |
5387327 | Khan | Feb 1995 | A |
5390671 | Lord et al. | Feb 1995 | A |
5391250 | Cheney, II et al. | Feb 1995 | A |
5395504 | Saurer et al. | Mar 1995 | A |
5400782 | Beaubiah | Mar 1995 | A |
5411647 | Johnson et al. | May 1995 | A |
5431160 | Wilkins et al. | Jul 1995 | A |
5437999 | Diebold et al. | Aug 1995 | A |
5469846 | Khan | Nov 1995 | A |
5491474 | Suni et al. | Feb 1996 | A |
5494562 | Maley et al. | Feb 1996 | A |
5496453 | Uenoyama et al. | Mar 1996 | A |
5497772 | Schulman et al. | Mar 1996 | A |
5531878 | Vadgama et al. | Jul 1996 | A |
5545191 | Mann et al. | Aug 1996 | A |
5560357 | Faupel et al. | Oct 1996 | A |
5562713 | Silvian | Oct 1996 | A |
5565085 | Ikeda et al. | Oct 1996 | A |
5567302 | Song et al. | Oct 1996 | A |
5568806 | Cheney, II et al. | Oct 1996 | A |
5569186 | Lord et al. | Oct 1996 | A |
5582184 | Erickson et al. | Dec 1996 | A |
5582697 | Ikeda et al. | Dec 1996 | A |
5582698 | Flaherty et al. | Dec 1996 | A |
5586553 | Halili et al. | Dec 1996 | A |
5589326 | Deng et al. | Dec 1996 | A |
5593852 | Heller et al. | Jan 1997 | A |
5596150 | Arndt et al. | Jan 1997 | A |
5617851 | Lipkovker | Apr 1997 | A |
5628890 | Carter et al. | May 1997 | A |
5651869 | Yoshioka et al. | Jul 1997 | A |
5660163 | Schulman et al. | Aug 1997 | A |
5670031 | Hintsche et al. | Sep 1997 | A |
5680858 | Hansen et al. | Oct 1997 | A |
5682233 | Brinda | Oct 1997 | A |
5695623 | Michel et al. | Dec 1997 | A |
5708247 | McAleer et al. | Jan 1998 | A |
5711297 | Iliff et al. | Jan 1998 | A |
5711861 | Ward et al. | Jan 1998 | A |
5711862 | Sakoda et al. | Jan 1998 | A |
5741211 | Renirie et al. | Apr 1998 | A |
5771001 | Cobb | Jun 1998 | A |
5791344 | Schulman et al. | Aug 1998 | A |
5800420 | Gross et al. | Sep 1998 | A |
5807375 | Gross et al. | Sep 1998 | A |
5820551 | Hill et al. | Oct 1998 | A |
5820622 | Gross et al. | Oct 1998 | A |
5822715 | Worthington et al. | Oct 1998 | A |
5827184 | Netherly et al. | Oct 1998 | A |
5840020 | Heinonen et al. | Nov 1998 | A |
5842983 | Abel et al. | Dec 1998 | A |
5885211 | Eppstein et al. | Mar 1999 | A |
5899855 | Brown | May 1999 | A |
5954643 | VanAntwerp et al. | Sep 1999 | A |
5954685 | Tierney | Sep 1999 | A |
5957854 | Besson et al. | Sep 1999 | A |
5964993 | Blubaugh et al. | Oct 1999 | A |
5971922 | Arita et al. | Oct 1999 | A |
6001067 | Shults et al. | Dec 1999 | A |
6024699 | Surwit et al. | Feb 2000 | A |
6093172 | Funderburk et al. | Jul 2000 | A |
6122351 | Schlueter, Jr. et al. | Sep 2000 | A |
6368141 | VanAntwerp et al. | Apr 2002 | B1 |
6368274 | Van Antwerp et al. | Apr 2002 | B1 |
6695860 | Ward et al. | Feb 2004 | B1 |
6936006 | Sabra | Aug 2005 | B2 |
20020130042 | Moerman et al. | Sep 2002 | A1 |
20030078560 | Miller et al. | Apr 2003 | A1 |
20040002682 | Kovelman et al. | Jan 2004 | A1 |
20040064133 | Miller et al. | Apr 2004 | A1 |
Number | Date | Country |
---|---|---|
29 03 216 | Aug 1979 | DE |
227 029 | Sep 1985 | DE |
3934299 | Oct 1990 | DE |
0 010 375 | Apr 1980 | EP |
0 026 995 | Apr 1981 | EP |
0 048 090 | Mar 1982 | EP |
0 078 636 | May 1983 | EP |
0 096 228 | Dec 1983 | EP |
0 098 592 | Jan 1984 | EP |
0 125 139 | Nov 1984 | EP |
0 127 958 | Dec 1984 | EP |
0 136 362 | Apr 1985 | EP |
0 170 375 | Feb 1986 | EP |
0 177 743 | Apr 1986 | EP |
0 080 304 | May 1986 | EP |
0 184 909 | Jun 1986 | EP |
0 206 218 | Dec 1986 | EP |
0 230 472 | Aug 1987 | EP |
0 241 309 | Oct 1987 | EP |
0 245 073 | Nov 1987 | EP |
0 278 647 | Aug 1988 | EP |
0 359 831 | Mar 1990 | EP |
0 368 209 | May 1990 | EP |
390 390 | Oct 1990 | EP |
0 400 918 | Dec 1990 | EP |
0 453 283 | Oct 1991 | EP |
0 470 290 | Feb 1992 | EP |
0 127 958 | Mar 1992 | EP |
0 255 291 | Jun 1992 | EP |
1394171 | May 1975 | GB |
1599241 | Sep 1981 | GB |
2 073 891 | Oct 1981 | GB |
2 154 003 | Feb 1988 | GB |
2 204 408 | Nov 1988 | GB |
2 254 436 | Oct 1992 | GB |
54-41191 | Apr 1979 | JP |
55-10581 | Jan 1980 | JP |
55-10583 | Jan 1980 | JP |
55-10584 | Jan 1980 | JP |
55-12406 | Jan 1980 | JP |
56-163447 | Dec 1981 | JP |
57-70448 | Apr 1982 | JP |
60-173457 | Sep 1985 | JP |
60-173458 | Sep 1985 | JP |
60-173459 | Sep 1985 | JP |
62-85855 | Apr 1987 | JP |
62-114747 | May 1987 | JP |
63-58149 | Mar 1988 | JP |
63-128252 | May 1988 | JP |
63-139246 | Jun 1988 | JP |
63-294799 | Dec 1988 | JP |
63-317757 | Dec 1988 | JP |
63-317758 | Dec 1988 | JP |
1-114746 | May 1989 | JP |
1-114747 | May 1989 | JP |
1-124060 | May 1989 | JP |
1-134244 | May 1989 | JP |
1-156658 | Jun 1989 | JP |
2-62958 | Mar 1990 | JP |
2-120655 | May 1990 | JP |
2-287145 | Nov 1990 | JP |
2-310457 | Dec 1990 | JP |
3-020752 | Jan 1991 | JP |
3-26956 | Feb 1991 | JP |
3-202764 | Sep 1991 | JP |
5-72171 | Mar 1993 | JP |
5-196595 | Aug 1993 | JP |
5-190050 | Jul 1994 | JP |
6-190050 | Jul 1994 | JP |
7-55757 | Mar 1995 | JP |
7-72585 | Mar 1995 | JP |
8-285814 | Nov 1996 | JP |
8-285815 | Nov 1996 | JP |
9-21778 | Jan 1997 | JP |
9-101280 | Apr 1997 | JP |
9-285459 | Nov 1997 | JP |
10-170471 | Jun 1998 | JP |
1281988 | Jan 1987 | SU |
WO 8905119 | Nov 1985 | WO |
WO 8908713 | Sep 1989 | WO |
WO 9005300 | May 1990 | WO |
WO 9005910 | May 1990 | WO |
WO 9101680 | Feb 1991 | WO |
WO 9104704 | Apr 1991 | WO |
WO 9115993 | Oct 1991 | WO |
WO 9213271 | Aug 1992 | WO |
WO 9420602 | Sep 1994 | WO |
WO 9427140 | Nov 1994 | WO |
WO 9630431 | Oct 1996 | WO |
WO 9635370 | Nov 1996 | WO |
WO 9702847 | Jan 1997 | WO |
WO 9719344 | May 1997 | WO |
WO 9742882 | Nov 1997 | WO |
WO 9742883 | Nov 1997 | WO |
WO 9742886 | Nov 1997 | WO |
WO 9742888 | Nov 1997 | WO |
WO 9743962 | Nov 1997 | WO |
WO 2004028337 | Apr 2004 | WO |
Number | Date | Country | |
---|---|---|---|
20040133164 A1 | Jul 2004 | US |
Number | Date | Country | |
---|---|---|---|
60424099 | Nov 2002 | US |